CEI
HRMY icon

Clark Estates Inc’s Harmony Biosciences HRMY Stock Holding History

Clark Estates Inc’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.96M Hold
81,300
– – 0.68% 32
2026
Q1 		$2.28M Buy
81,300
+14,000
+21% +$459K 0.55% 41
2025
Q4 		$2.52M Hold
67,300
– – 0.61% 31
2025
Q3 		$1.85M Buy
67,300
+7,300
+12% +$251K 0.42% 71
2025
Q2 		$1.9M Hold
60,000
– – 0.43% 51
2025
Q1 		$1.99M Buy
+60,000
New +$2.15M 0.42% 47

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Clark Estates Inc's HRMY Position: Q2 2026 in Review

Clark Estates Inc held its Harmony Biosciences (HRMY) position steady in Q2 2026 at 81,300 shares worth $2.96M. The position accounts for 0.68% of the portfolio, ranked #32.

Clark Estates Inc first reported a position in HRMY in Q1 2025 and has held it in 6 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Clark Estates Inc held 81,300 shares of Harmony Biosciences worth $2.96M as of Q2 2026.
  • Clark Estates Inc left its Harmony Biosciences share count unchanged in Q2 2026.
  • Harmony Biosciences made up 0.68% of Clark Estates Inc's portfolio in Q2 2026, its #32 holding.
  • Clark Estates Inc first reported a position in Harmony Biosciences in Q1 2025 and has held it in 6 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Clark Estates Inc's 13F filing for Q2 2026, filed 5 Aug 2026.